Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma.
Mol Carcinog. 2023 Nov;62(11):1717-1730. doi: 10.1002/mc.23610. Epub 2023 Jul 26.
Mol Carcinog. 2023.
PMID: 37493106
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant models.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, Jeong AD, Guntupalli SR, Behbakht K, Gbaja V, Arnoult N, Chuong EB, Bitler BG.
Nguyen LL, et al.
bioRxiv [Preprint]. 2023 Feb 23:2023.02.23.529773. doi: 10.1101/2023.02.23.529773.
bioRxiv. 2023.
PMID: 36865165
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite